ExamPat

Alan D Diamond

USPTO Patent Examiner·Active 2012 to 2026

Alan D Diamond is a USPTO patent examiner who has handled 73 ex parte reexaminations between 2012 and 2026, with 10 currently open. These reexams concentrate in Life Sciences & Consumer, Chemistry & Materials, and Electrical & Electronic. ExamPat indexes the full prosecution record for each of these cases, including office-action grounds, certificate outcomes, and downstream PTAB and federal-circuit decisions.

Filings by year

10
12
3
13
9
14
7
15
5
17
3
18
4
19
3
20
3
21
7
22
6
23
2
24
6
25
5
26

Technology mix

Life Sciences & Consumer31 (42%)
Chemistry & Materials27 (37%)
Electrical & Electronic13 (18%)
Mechanical Engineering1 (1%)
Physics & Instruments1 (1%)

Compare against all examiners

Eight side-by-side metrics: case volume, pendency, OAs per reexam, rejection mix, SNQ denial rate, certification rate, and PTAB appeal rate, with a Δ column showing where this examiner runs higher or lower than the corpus.

  • Average and median pendency, both for this examiner and the corpus
  • Rejection basis split (102 / 103 / 112) head-to-head
  • Certification, SNQ denial, and PTAB appeal rates

Certificate outcome distribution

How this examiner's certificates split across the six possible outcomes: all claims confirmed, confirmed with amendment, confirmed with new claims, mixed, or all claims canceled. Includes share comparison to the corpus distribution.

  • Count and share for each of the six outcome buckets
  • Δ vs. corpus distribution in percentage points
  • Useful for setting realistic patent-owner expectations

Event-to-event timing

Median time for this examiner's cases at each prosecution stage — filing to first office action, filing to NIRC, and filing to certificate — with corpus comparison and sample size.

  • Median in months per transition
  • Side-by-side with the corpus median
  • n column showing how many of this examiner's cases completed each transition

Recent reexaminations (showing 25 of 73)

Control #FiledPatentTitlePendencyStatus
90/016,207Apr 24, 202612,586,696MAGNETIZED CABLES FOR IMPROVED CABLE MANAGEMENT—Open
90/016,178Apr 14, 202612,329,738UROLITHIN A AND A COMPOSITION CONTAINING SAME FOR EXTERNAL USE IN INFLAMMATIONS OF VARIOUS ETIOLOGIES—Open
90/016,021Mar 2, 202611,207,280EPINEPHRINE COMPOSITIONS AND CONTAINERS—Open
90/015,927Jan 30, 202612,533,328EPINEPHRINE COMPOSITIONS AND CONTAINERS—Open
90/015,899Jan 21, 20269,349,655METHOD FOR MECHANICAL STRESS ENHANCEMENT IN SEMICONDUCTOR DEVICES—Open
90/015,851Dec 31, 202512,508,238EPINEPHRINE COMPOSITIONS AND CONTAINERS—Open
90/015,635Oct 24, 202511,147,878ANIMAL PROTEIN-FREE PHARMACEUTICAL COMPOSITIONS—Open
90/015,512Sep 12, 202511,230,521MONOAMINE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME—Open
90/015,486Aug 28, 202511,147,782GHB FORMULATION AND METHOD FOR ITS MANUFACTURE—Open
90/015,342Jun 25, 20259,605,152ASPHALT COMPOSITIONS FOR ROOFING APPLICATIONS, METHODS FOR MAKING THE SAME, AND FILLED ASPHALT MATERIAL COMPRISING THE SAME—Open
90/019,810Jan 13, 20259,814,256METHOD FOR PROCESSING CRUSTACEANS TO PRODUCE LOW FLUORIDE/LOW TRIMETHYL AMINE PRODUCTS THEREOF8 moClosed
90/019,744Nov 26, 202410,392,353NOVEL PROCESSES FOR MAKING SUBSTITUTED QUINAZOLINE COMPOUNDS USING HYDROGEN BONDING CATALYSTS10 moClosed
90/019,368Jan 8, 202411,655,240CRYSTAL FORM OF COMPOUND AND FUMARIC ACID, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING CORONAVIRUS-INDUCED DISEASES25 moClosed
90/019,345Dec 20, 202311,116,740Methods for Use in Support of Planned Supplement and Food Ingredient Products for Diagnosis and Treatment of Metabolic Syndrome10 moClosed
90/019,315Nov 30, 202311,565,982Process for Conversion of Carbon Dioxide and Power into Fuels and Chemicals.9 moClosed
90/019,314Nov 30, 202311,560,343Process for capture of carbon dioxide from air and the direct conversion of carbon dioxide into fuels and chemicals11 moClosed
90/015,307Oct 2, 202311,661,402PSMA-TARGETING COMPOUNDS AND USES THEREOF6 moClosed
90/015,257Jul 11, 202311,655,383PHOTOCHROMIC COMPOSITIONS, MARKERS CONTAINING THE SAME, AND SYSTEMS AND METHODS FOR THEIR USE8 moClosed
90/015,243Jun 1, 202311,279,658COMPOSITIONS FOR IMPROVED CONCRETE PERFORMANCE8 moClosed
90/015,179Dec 20, 202211,292,725METHOD FOR RECOVERING LITHIUM HYDROXIDE23 moClosed
90/015,145Oct 27, 202211,141,420Flavanones For Use In Treating Visceral Hypersensitivity13 moClosed
90/015,136Oct 17, 20229,102,585EFFICIENT CONTINUOUS PROCESS FOR MANUFACTURING OF 4-AMINODIPHENYLAMINE FROM ANILINE AND NITROBENZENE9 moClosed
90/015,089Aug 9, 202211,186,598Radioactive Phospholipid Metal Chelates for Cancer Imaging and Therapy11 moClosed
90/015,075Jul 20, 20229,119,823NITRITE FORMULATIONS AND THEIR USE AS NITRIC OXIDE PRODRUGS17 moClosed
90/015,001Apr 8, 20229,241,999Method of producing physiological and therapeutic levels of nitric oxide through an oral delivery system34 moClosed

Other USPTO reexam examiners

Get the full reexam analytics

Compare Alan D Diamond against the full corpus, see the certificate-outcome split, drill into event timing, filter the case list, and export. Free to sign up.